Preparing for Your First Chemotherapy Session: What the Evidence Actually Supports
From antiemetics and dental checkups to fertility counseling and fasting research, here's what's proven and what's still being studied.

Key Takeaways
- •Chemotherapy drugs target rapidly dividing cells, which explains why healthy tissues like hair follicles, the gut lining, and bone marrow are also affected.
- •Giving antiemetic medication before chemotherapy starts is far more effective at preventing nausea and vomiting than treating it after symptoms appear.
- •Chemotherapy-induced neutropenia raises infection risk, making pre-treatment counseling on hygiene and infection prevention clinically important.
- •A dental evaluation before chemotherapy can catch oral health problems that might otherwise worsen into mucositis or infection during treatment.
- •Short-term fasting before chemotherapy has shown feasibility in small early studies, but the evidence remains preliminary and isn't part of standard care.
- •Exercise before and during treatment, known as prehabilitation, is associated with better treatment tolerance and fewer treatment-related adverse effects.
- •Psychological preparation and clear patient education before the first infusion can meaningfully reduce treatment-related anxiety.
- •Fertility preservation options should be discussed before starting chemotherapy regimens that may affect reproductive function, since timing matters.
The first day of chemotherapy often carries more uncertainty than the treatment itself. Patients want to know what to expect, and whether anything they do beforehand actually changes how the weeks ahead feel. Some of the answers are well established, backed by decades of clinical research pointing to specific, practical steps. Others, like fasting before treatment, are still being studied and don't yet belong in that same category. This article walks through what the evidence actually supports, and what remains open.
Why Chemotherapy Causes the Side Effects It Does
Chemotherapy drugs were designed to interrupt cell division. Cancer cells divide unusually fast, which is exactly what makes many chemotherapy drugs effective against them. But the drugs can't tell the difference between a fast-dividing tumor cell and a fast-dividing healthy one.
Hair follicles, the lining of the mouth and gut, and the stem cells that make blood cells in bone marrow all divide quickly too. That overlap is why chemotherapy so often causes hair loss, mouth sores, and a drop in blood cell counts. It isn't a flaw in the treatment; it's a direct consequence of how the drugs work. Understanding this mechanism explains why so much pre-treatment preparation focuses on the mouth, the immune system, and the body's general reserve rather than the tumor itself.
Getting Ahead of Nausea Before It Starts
Nausea and vomiting are among the side effects patients fear most, known in oncology as chemotherapy-induced nausea and vomiting, or CINV. Timing matters here: medications that prevent nausea work far better when given before chemotherapy starts than after symptoms appear.
Which antiemetic combination makes sense depends on how likely a specific chemotherapy regimen is to cause vomiting, a property oncologists call emetogenic risk. Clinical guidelines now recommend tailoring preventive antiemetics to that risk level before the first dose is ever given. This is one of the more settled areas of preparation, and patients can reasonably expect their care team to have an antiemetic plan ready on day one.
Lowering Infection Risk Before Treatment Starts
Bone marrow suppression doesn't just lower blood cell counts in general. It specifically reduces neutrophils, the white blood cells most responsible for fighting bacterial infection. This drop, called neutropenia, can leave patients vulnerable right when their defenses are already weaker. Clinical guidelines recommend that patients receive counseling on infection prevention, such as hand hygiene and avoiding certain exposures, before this window arrives rather than after.
The mouth is a common entry point for infection during chemotherapy, because mucositis, the painful inflammation and sores that can develop in the lining of the mouth and digestive tract, breaks down a natural barrier. A dental evaluation before treatment starts can catch existing problems, like untreated cavities or gum disease, before they become a source of infection once that lining is compromised.
Getting the Logistics Right: Access and Hydration
Many chemotherapy regimens are given through a vein, and planning ahead for this matters more than it might seem. Some chemotherapy drugs are vesicants, meaning they can damage surrounding tissue if they leak outside the vein. For patients expected to need repeated infusions, oncology teams often recommend placing a central venous catheter, a small device tucked under the skin that gives reliable access to a large vein, before treatment begins rather than during an emergency.
Hydration is another piece of groundwork, and the details depend on the specific drug being used. Cisplatin-based chemotherapy, for example, carries a known risk of kidney toxicity, and adequate hydration before and during treatment is a recommended way to reduce that risk. These protocols are regimen-specific, which is why the exact plan should come from the treating oncology team.
Fasting Before Chemotherapy: Promising but Unproven
Short-term fasting before chemotherapy has attracted attention as a possible way to ease side effects, and it's worth understanding what the research so far actually shows. An early case series, work associated with Valter Longo's research group, first suggested that short periods without food around chemotherapy might be tolerable and worth studying further. Since then, a small randomized pilot study in breast cancer patients and a separate safety and feasibility study in patients receiving platinum-based chemotherapy have added more data.
Together, these studies suggest fasting before chemotherapy is feasible for some patients and hasn't raised major safety concerns in the settings tested. That is a long way from proof that it actually reduces side effects or deserves a place in standard preparation. The studies involved are small and early-stage, not designed to answer whether fasting changes outcomes. Anyone considering this should raise it with their oncology team rather than attempt it independently, since fasting interacts with nutrition needs that vary by person and regimen.
Building Physical Reserve Before Treatment Begins
Exercise before and during cancer treatment, sometimes called prehabilitation, rests on a different evidence base than fasting does. Research reviewing exercise's relationship to cancer treatment has found it associated with better treatment tolerance and fewer treatment-related adverse effects. The idea is fairly intuitive: a body with more physical reserve going into a demanding treatment tends to handle that demand better, the way training before a long hike makes the hike itself less punishing.
This doesn't mean exercise changes how chemotherapy works against a tumor. The evidence here concerns tolerance and function, not treatment efficacy. Even so, building some physical activity into the weeks before a first infusion is one of the more consistently supported pieces of preparation available to patients.
Preparing Mentally for the First Infusion
The anticipation of chemotherapy can generate as much distress as the treatment itself. Evidence-based approaches to anxiety in cancer patients show that psychological preparation and patient education before treatment starts can reduce that anxiety and improve coping. Knowing what to expect on the first day, understanding why certain side effects happen, and having a plan for managing them all appear to make the experience more manageable.
This kind of preparation supports comfort and coping. It isn't a treatment itself, and it shouldn't be framed as something that changes how well chemotherapy works against cancer. But for many patients, having accurate expectations removes a layer of fear from an already difficult day.
Fertility Considerations Before Starting Treatment
Some chemotherapy regimens affect reproductive function, a consequence of the same cell-killing action that makes them effective against cancer, since the cells involved in producing eggs and sperm divide and mature on their own cycles. Clinical guidelines recommend that fertility preservation, meaning options such as egg or sperm freezing used to protect future reproductive potential, be discussed with patients before starting treatment known to carry this risk.
This conversation matters most before the first dose, because some preservation options need time to arrange. For patients of reproductive age facing a gonadotoxic regimen, raising the topic early with the oncology team keeps options open that may not exist once treatment has begun. Not every regimen carries meaningful fertility risk, which is why this is a conversation for a specific care team rather than a universal rule.
Taken together, the steps that matter most before a first chemotherapy session range from the well-established, like antiemetics and dental checks, to the still-unfolding, like fasting. The common thread is that none of them substitute for a conversation with the treating oncology team, who can match preparation to the specific drugs and person involved.
Common Questions
References
- Vincent T. DeVita, Edward Chu (2008). A History of Cancer Chemotherapy
- Rudolph M. Navari, Matti Aapro (2016). Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting
- (2020). Antiemetics: ASCO Guideline Update.
- Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz, Michael J. Boeckh, James I. Ito, Craig A. Mullen, Issam I. Raad, Kenneth V. Rolston, Jo-Anne H. Young, John R. Wingard (2011). Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
- Rajesh V. Lalla, Joanne Bowen, Andrei Barasch, Linda Elting, Joel Epstein, Dorothy M. Keefe, Deborah B. McGuire, Cesar Migliorati, Ourania Nicolatou‐Galitis, Douglas E. Peterson, Judith E. Raber‐Durlacher, Stephen T. Sonis, Sharon Elad (2014). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
- Fernando M. Safdie, Tanya Dorff, David Quinn, Luigi Fontana, Min Wei, Changhan Lee, Pinchas Cohen, Valter D. Longo (2009). Fasting and cancer treatment in humans: A case series report
- Stefanie de Groot, Maaike PG Vreeswijk, Marij JP Welters, Gido Gravesteijn, Jan JWA Boei, Anouk Jochems, Daniel Houtsma, Hein Putter, Jacobus JM van der Hoeven, Johan WR Nortier, Hanno Pijl, Judith R Kroep (2015). The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study
- Tanya B. Dorff, Susan Groshen, Agustin Garcia, Manali Shah, Denice Tsao-Wei, Huyen Pham, Chia-Wei Cheng, Sebastian Brandhorst, Pinchas Cohen, Min Wei, Valter Longo, David I. Quinn (2016). Safety and feasibility of fasting in combination with platinum-based chemotherapy
- Prue Cormie, Eva M Zopf, Xiaochen Zhang, Kathryn H Schmitz (2017). The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects
- Lara Traeger, Joseph A. Greer, Carlos Fernandez-Robles, Jennifer S. Temel, William F. Pirl (2012). Evidence-Based Treatment of Anxiety in Patients With Cancer
- Kutluk Oktay, Brittany E. Harvey, Ann H. Partridge, Gwendolyn P. Quinn, Joyce Reinecke, Hugh S. Taylor, W. Hamish Wallace, Erica T. Wang, Alison W. Loren (2018). Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
- Vincent Launay-Vacher, Jean-Baptiste Rey, Corinne Isnard-Bagnis, Gilbert Deray, Mikael Daouphars (2008). Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care
Team Review: This article has been reviewed by Canceria Research Team

